These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 16611303)

  • 21. Autoimmune lymphoproliferative syndrome associated with severe humoral immunodeficiency and monoclonal gammopathy.
    Nanan R; Ströbel P; Haas JP; Marx A; Kreth HW
    Ann Hematol; 2002 Jun; 81(6):332-5. PubMed ID: 12107564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correction of Fas (CD95) deficiency by haploidentical bone marrow transplantation.
    Benkerrou M; Le Deist F; de Villartay JP; Caillat-Zucman S; Rieux-Laucat F; Jabado N; Cavazzana-Calvo M; Fischer A
    Eur J Immunol; 1997 Aug; 27(8):2043-7. PubMed ID: 9295043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Residual CD95-pathway function in children with autoimmune lymphoproliferative syndrome is independent from clinical state and genotype of CD95 mutation.
    Fuchs H; Posovszky C; Lahr G; van der Werff ten Bosch J; Boehler T; Debatin KM
    Pediatr Res; 2009 Feb; 65(2):163-8. PubMed ID: 18948840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical, immunological, and pathological consequences of Fas-deficient conditions.
    Le Deist F; Emile JF; Rieux-Laucat F; Benkerrou M; Roberts I; Brousse N; Fischer A
    Lancet; 1996 Sep; 348(9029):719-23. PubMed ID: 8806292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new disorder of lymphocyte apoptosis: combination of autoimmunity, infectious lymphadenopathy, double negative T cells, and impaired activation-induced cell death.
    Hundt M; Posovszky C; Schmidt RE
    Immunobiology; 2002 Dec; 206(5):514-8. PubMed ID: 12607726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dominant inhibition of Fas ligand-mediated apoptosis due to a heterozygous mutation associated with autoimmune lymphoproliferative syndrome (ALPS) Type Ib.
    Bi LL; Pan G; Atkinson TP; Zheng L; Dale JK; Makris C; Reddy V; McDonald JM; Siegel RM; Puck JM; Lenardo MJ; Straus SE
    BMC Med Genet; 2007 Jul; 8():41. PubMed ID: 17605793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoimmune lymphoproliferative syndrome: a syndrome associated with inherited genetic defects that impair lymphocytic apoptosis--CT and US features.
    Avila NA; Dwyer AJ; Dale JK; Lopatin UA; Sneller MC; Jaffe ES; Puck JM; Straus SE
    Radiology; 1999 Jul; 212(1):257-63. PubMed ID: 10405750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigation of suspected deficient Fas-mediated apoptosis in a father and son.
    Hanlon MG; Gacis ML; Kakakios AM; Kilham H
    Cytometry; 2001 Mar; 43(3):195-8. PubMed ID: 11170106
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoimmune lymphoproliferative syndrome: etiology, diagnosis, and management.
    van der Werff ten Bosch J
    Paediatr Drugs; 2003; 5(3):185-93. PubMed ID: 12608883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoimmune lymphoproliferative syndrome in a patient with a new minimal deletion in the death domain of the FAS gene.
    Gualco G; van den Berg A; Koopmans S; Bacchi LM; Carneiro SS; Ruiz E; Vecchi AP; Chan JK
    Hum Pathol; 2008 Jan; 39(1):137-41. PubMed ID: 18070632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II.
    Wang J; Zheng L; Lobito A; Chan FK; Dale J; Sneller M; Yao X; Puck JM; Straus SE; Lenardo MJ
    Cell; 1999 Jul; 98(1):47-58. PubMed ID: 10412980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of new Fas mutations in a patient with autoimmune lymphoproliferative syndrome (ALPS) and eosinophilia.
    Aspinall AI; Pinto A; Auer IA; Bridges P; Luider J; Dimnik L; Patel KD; Jorgenson K; Woodman RC
    Blood Cells Mol Dis; 1999; 25(3-4):227-38. PubMed ID: 10575548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spotlight on autoimmune lymphoproliferative syndrome.
    Ferrer E; Moral MA; Bozzo J
    Drug News Perspect; 2007 May; 20(4):260-2. PubMed ID: 17637938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoimmune lymphoproliferative syndrome: report of two cases and review of the literature.
    Oren H; Ozkal S; Gülen H; Duman M; Uçar C; Atabay B; Yilmaz S; Kargi A; Irken G
    Ann Hematol; 2002 Nov; 81(11):651-3. PubMed ID: 12454704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis.
    Sneller MC; Wang J; Dale JK; Strober W; Middelton LA; Choi Y; Fleisher TA; Lim MS; Jaffe ES; Puck JM; Lenardo MJ; Straus SE
    Blood; 1997 Feb; 89(4):1341-8. PubMed ID: 9028957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autoimmune lymphoproliferative syndrome presenting with glomerulonephritis.
    Kanegane H; Vilela MM; Wang Y; Futatani T; Matsukura H; Miyawaki T
    Pediatr Nephrol; 2003 May; 18(5):454-6. PubMed ID: 12736807
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inactivation of the Fas gene by Alu insertion: retrotransposition in an intron causing splicing variation and autoimmune lymphoproliferative syndrome.
    Tighe PJ; Stevens SE; Dempsey S; Le Deist F; Rieux-Laucat F; Edgar JD
    Genes Immun; 2002 Oct; 3 Suppl 1():S66-70. PubMed ID: 12215906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A genetic disorder of lymphocyte apoptosis involving the fas pathway: the autoimmune lymphoproliferative syndrome.
    Fleisher TA; Straus SE; Bleesing JJ
    Curr Allergy Asthma Rep; 2001 Nov; 1(6):534-40. PubMed ID: 11895618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical, immunological, and genetic features in 780 patients with autoimmune lymphoproliferative syndrome (ALPS) and ALPS-like diseases: A systematic review.
    Hafezi N; Zaki-Dizaji M; Nirouei M; Asadi G; Sharifinejad N; Jamee M; Erfan Rasouli S; Hamedifar H; Sabzevari A; Chavoshzadeh Z; Yazdani R; Abolhassani H; Aghamohammadi A; Azizi G
    Pediatr Allergy Immunol; 2021 Oct; 32(7):1519-1532. PubMed ID: 33963613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The autoimmune lymphoproliferative syndrome: an experiment of nature involving lymphocyte apoptosis.
    Fleisher TA
    Immunol Res; 2008; 40(1):87-92. PubMed ID: 18193364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.